Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126514575 | 12651457 | 5 | F | 20160804 | 20160815 | 20160902 | EXP | IT-TEVA-683497ACC | TEVA | EDOARDO R. A CASE OF NEUROLEPTIC MALIGNANT SYNDROME AFTER BREAST REDUCTION SURGERY IN A SCHIZOPHRENIC PATIENT. SURGICAL CHRONICLES. 2016 JAN 01;21(1):41-43. | 49.00 | YR | F | Y | 0.00000 | 20160902 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126514575 | 12651457 | 1 | SS | QUETIAPINE. | QUETIAPINE | 1 | Oral | U | 0 | 100 | MG | FILM-COATED TABLET | |||||||
| 126514575 | 12651457 | 2 | SS | CISATRACURIUM. | CISATRACURIUM | 1 | Unknown | U | 0 | 29 | MG | ||||||||
| 126514575 | 12651457 | 3 | PS | FENTANYL. | FENTANYL | 1 | Unknown | U | 20747 | 500 | MG | ||||||||
| 126514575 | 12651457 | 4 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | GTT 10ML/15MG, 40 GTT | U | 0 | |||||||||
| 126514575 | 12651457 | 5 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | U | 0 | 200 | MG | ||||||||
| 126514575 | 12651457 | 6 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Unknown | U | 0 | 2 | MG | ||||||||
| 126514575 | 12651457 | 7 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | GTT 2.5 MG/ML, 20 GTT | U | 0 | |||||||||
| 126514575 | 12651457 | 8 | SS | morphine | MORPHINE | 1 | Unknown | U | 0 | 5 | MG | ||||||||
| 126514575 | 12651457 | 9 | SS | ATROPINE. | ATROPINE | 1 | Unknown | U | 0 | .5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126514575 | 12651457 | 1 | Schizophrenia |
| 126514575 | 12651457 | 2 | General anaesthesia |
| 126514575 | 12651457 | 3 | General anaesthesia |
| 126514575 | 12651457 | 4 | Schizophrenia |
| 126514575 | 12651457 | 5 | General anaesthesia |
| 126514575 | 12651457 | 6 | General anaesthesia |
| 126514575 | 12651457 | 7 | Schizophrenia |
| 126514575 | 12651457 | 8 | General anaesthesia |
| 126514575 | 12651457 | 9 | General anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126514575 | 12651457 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126514575 | 12651457 | Neuroleptic malignant syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |